Meyka AI API is live for developers.Start building.
Advertisement
Dechra Pharmaceuticals PLC

Dechra Pharmaceuticals PLC (DPHAY) Stock Overview

Explore Dechra Pharmaceuticals PLC’s financial performance, market position, analyst ratings, and future outlook.

DPHAY●PNK
HealthcareDrug Manufacturers - General
$98.00
$1.90(1.98%)
U.S. Market opens in 54h 21m
Advertisement

Dechra Pharmaceuticals PLC (DPHAY)

Meyka AI Score

Z

Key Financials

Market Cap5.6B
P/E Ratio-298.94
EPS (TTM)$-0.63
ROE-0.04%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$155.63

DPHAY Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Dechra Pharmaceuticals PLC (DPHAY) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $155.63.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -298.94 and a market capitalization of 5.6B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
1.98%
3-Month Change
3.95%
6-Month Change
3.95%
Year-to-Date (YTD) Change
3.95%
1-Year Change
31.92%
3-Year Change
41.007%
5-Year Change
44.12%
All-Time (Max) Change
44.12%

Contact Information

https://www.dechra.com
44 1606 814730
24 Cheshire Avenue, Northwich, NaN, CW9 7UA

Company Facts

24,570 Employees
IPO DateFeb 26, 2018
CountryGB

Frequently Asked Questions